Impact of Breast Center Accreditation on Compliance with Breast Quality Performance Measures at Commission on Cancer-Accredited Centers

Purpose This study was designed to determine whether accreditation by the National Accreditation Program for Breast Centers (NAPBC) is associated with improved performance on six breast quality measures pertaining to adjuvant treatment, needle/core biopsy, and breast conservation therapy rates at Co...

Full description

Saved in:
Bibliographic Details
Published in:Annals of surgical oncology 2019-05, Vol.26 (5), p.1202-1211
Main Authors: Miller, Megan E., Bleicher, Richard J., Kaufman, Cary S., Kurtzman, Scott H., Chang, Cecilia, Wang, Chi-Hsiung, Pollitt, Karen A., Connolly, James, Winchester, David P., Yao, Katharine A.
Format: Article
Language:English
Subjects:
Accreditation
Biopsy
Breast cancer
Compliance
Health Services Research and Global Oncology
Medicine
Medicine & Public Health
Oncology
Patients
Quality
Surgery
Surgical Oncology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose This study was designed to determine whether accreditation by the National Accreditation Program for Breast Centers (NAPBC) is associated with improved performance on six breast quality measures pertaining to adjuvant treatment, needle/core biopsy, and breast conservation therapy rates at Commission on Cancer (CoC) centers. Methods National Cancer Database 2015 data were retrospectively reviewed to compare patients treated at CoC centers with and without NAPBC accreditation for compliance on six breast cancer quality measures. Mixed effects modeling determined performance on the quality measures adjusting for patient, tumor, and facility factors. Results Of 1308 CoC facilities, 484 (37%) were NAPBC-accredited and 111,547 patients (48%) were treated at NAPBC centers. More than 80% of patients treated at both NAPBC and non-NAPBC centers received care in compliance with breast quality measures. NAPBC centers achieved significantly higher performance on four of the five quality measures than non-NAPBC centers at the patient level and on five of six measures at the facility level. For two measures, needle/core biopsy before surgical treatment of breast cancer and breast conservation therapy rate of 50%, NAPBC centers were twice as likely as non-NAPBC centers to perform at the level expected by the CoC (respectively odds ratio [OR] 1.96, 95% confidence interval [CI] 1.85–2.08, p  
ISSN:1068-9265
1534-4681
DOI:10.1245/s10434-018-07108-7